26 completed, 6 terminated, 4 unknown, 2 withdrawn. 39 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 39 | Completed 26, Terminated 6, Unknown 4, Withdrawn 2, Not yet recruiting 1 |
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Not yet recruiting 1 |
Follow Teriparatide: new trials by email Literature Review of Teriparatide trials Research Report on Teriparatide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PROactive HEALing in High-Risk Pelvic and Non-hip Lower Extremity Fragility Fractures (PRO HEAL Pilot) subcutaneous Teriparatide injection - Lower Extremity Fractures, Pelvis | Phase 1 / Phase 2 | Not yet recruiting | University of Calgary | 54 | 2027-03-15 | 2026-10-06 |
| Efficacy of WJ-derived Mesenchymal Stem Cells in Combination With Parathyroid Hormone for Vertebral Compression Fracture WJ-MSC, Teriparatide - Vertebral Compression Fracture, Osteoporotic Fractures | Phase 2 | Unknown | Inbo Han | 30 | 2020-09-01 | 2021-08-24 |
| A Six-month Phase 2 Study of Oral hPTH(1-34) (EBP05) in Postmenopausal Women With Low Bone Mass EBP05, Placebo of EBP05 - Osteoporosis | Phase 2 | Completed | Entera Bio Ltd. | 161 | 2019-06-30 | 2021-06-28 |
| Examination How the Administration Period of Teriparatide Affects Bone Metabolism and Bone Mineral Density Prior to Denosumab Therapy "Teriparatide", "Forteo® or Teribon" - Osteoporosis | Phase 2 | Unknown | Shinshu University | 90 | 2018-10-09 | 2021-09-21 |
| Recombinant Human rhPTH(1-34) VS Association Alfacalcidol/Hydrochlorothiazide in Severe Primary Hypoparathyroidism Teriparatide, Thiazide, Potassium sparing diuretic - Autosomal Dominant Hypocalcemia OR Primary Hypoparathyroidism Related to Other Cause But Complicated by Hypercalciuria Under Treatment | Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 16 | 2017-06-06 | 2021-06-28 |
| Teriparatide as a Chondroregenerative Therapy in OA Teriparatide, Placebo - Knee Osteoarthritis, Cartilage Degeneration | Phase 2 | Completed | Christopher Ritchlin | 76 | 2017-05-01 | 2023-05-12 |
| PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled Trial Teriparatide Prefilled Syringe, Placebo - Osteoporotic Fractures | Phase 2 | Completed | Hospital for Special Surgery, New York | 35 | 2017-05-01 | 2022-07-27 |
| A Pilot Study to Assess the Safety and Efficacy of Oral PTH (1-34) in the Treatment of Hypoparathyroidism EnteraBio's Oral Parathyroid Hormone (1-34) - Hypoparathyroidism | Phase 2 | Completed | Entera Bio Ltd. | 20 | 2014-07-01 | 2015-10-07 |
| Efficacy of Teriparatide in Diabetic Inactive Charcot Neuroarthropathy of Foot Teriparatide, Placebo - Diabetic Neuropathic Arthropathy | Phase 2 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 20 | 2014-01-01 | 2021-06-30 |
| 12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI) Teriparatide, Vibration - Spinal Cord Injury, Bone Loss | Phase 2 | Completed | Northwestern University | 25 | 2013-01-01 | 2023-05-10 |
| The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis Imperfecta Zoledronic acid, Teriparatide, No active treatment - Osteogenesis Imperfecta | Phase 2 | Terminated | University of Aarhus | 9 | 2012-11-01 | 2021-06-25 |
| Forteo Trial on Idiopathic Osteoporosis in Premenopausal Women Teriparatide, Saline Placebo - Adult Idiopathic Generalized Osteoporosis | Phase 2 | Completed | Elizabeth Shane | 41 | 2012-08-02 | 2019-12-11 |
| Study to Evaluate Effect of Intranasal Teriparatide on Serum P1NP, a Biomarker of Bone Formation, in Postmenopausal Women With Low Bone Mass ZT-034 Low Dose Nasal Spray, ZT-034 Mid Dose Nasal Spray, ZT-034 High Dose Nasal Spray - Osteoporosis, Osteopenia | Phase 2 | Unknown | Azelon Pharmaceuticals | 130 | 2011-11-01 | 2012-05-23 |
| The Impact of Parathyroid Hormone (PTH) on Craniofacial Osseous Regeneration in Bone Teriparatide, Placebo - Implant | Phase 2 | Terminated | University of Michigan | 27 | 2011-02-01 | 2018-02-07 |
| Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of PTH Analog Tablets in Postmenopausal Women PTH analog, Placebo, Forsteo (Teriparatide) - Postmenopausal Osteoporosis | Phase 2 | Completed | Unigene Laboratories Inc. | 97 | 2011-02-01 | 2013-03-01 |
| Teriparatide for Postsurgical Hypoparathyroidism Teriparatide - Hypoparathyroidism Post-surgical | Phase 2 | Terminated | Mayo Clinic | 5 | 2010-11-01 | 2014-12-22 |
| Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury Teriparatide, vibration - Spinal Cord Injury, Bone Loss | Phase 2 | Completed | Thomas J. Schnitzer | 60 | 2010-10-01 | 2025-12-02 |
| Teriparatide for Improved Knee Prosthesis Fixation teriparatide - Osteoarthritis of the Knee | Phase 2 | Completed | University Hospital, Linkoeping | 60 | 2010-02-01 | 2013-06-19 |
| A Study for the Transdermal Application of Teriparatide Subcutaneous Teriparatide, Transdermal Teriparatide - Osteoporosis | Phase 2 | Completed | Eli Lilly and Company | 233 | 2009-11-01 | 2012-10-23 |
| Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density Placebo to Romosozumab, Alendronate, Teriparatide - Low Bone Mineral Density, Postmenopausal Osteoporosis | Phase 2 | Completed | Amgen | 419 | 2009-06-03 | 2022-09-22 |
Showing 20 of 39. Sign in to see all of them.
Osteoporosis (23) · Bone Diseases, Metabolic (8) · Hypoparathyroidism (4) · Osteoporotic Fractures (3) · Bone Diseases (2) · Fractures, Bone (2) · Hip Fractures (2) · Osteoarthritis, Knee (2) · Osteoporosis, Postmenopausal (2) · Spinal Cord Injuries (2) · Anemia, Aplastic (1) · Anemia, Refractory, with Excess of Blasts (1) · Anorexia Nervosa (1) · Back Pain (1) · Bone Resorption (1)
Eli Lilly and Company (3) · Massachusetts General Hospital (3) · Entera Bio Ltd. (2) · Helen Hayes Hospital (2) · Amgen (1) · Assistance Publique - Hôpitaux de Paris (1) · Azelon Pharmaceuticals (1) · Christopher Ritchlin (1) · Columbia University (1) · Elizabeth Shane (1) · GlaxoSmithKline (1) · Glostrup University Hospital, Copenhagen (1) · Hospital for Special Surgery, New York (1) · Inbo Han (1) · John P. Bilezikian (1)
United States (21) · Denmark (4) · Israel (3) · Mexico (3) · Argentina (2) · Estonia (2) · Hungary (2) · Japan (2) · Poland (2) · Romania (2) · South Korea (2) · Sweden (2) · Australia (1) · Belgium (1) · Canada (1)
Adi Cohen, MD (2) · Elizabeth Shane, MD (2) · Agnes Linglart, MD, PhD (1) · Anil Bhansali, DM (1) · Anne Blanchard, MD, PhD (1) · Arthur Santora, MD (1) · Benjamin Z Leder, MD (1) · Bente Langdahl, MD (1) · Bettina S Nedergaard, MD (1) · Brian MacDonald (1) · Christence S Teglbjaerg, MD (1) · Christopher Ritchlin, MD (1) · Colleen Delaney, MD (1)
PMID 19401368, PMID 19594305, PMID 19858319, PMID 21593114, PMID 22766223, PMID 23234813, PMID 23543660, PMID 23683600, PMID 23719683, PMID 24382002, PMID 24420643, PMID 24684466, PMID 25393645, PMID 26144908, PMID 26358172, PMID 26964731, PMID 29972871, PMID 30334093, PMID 30355512, PMID 32876328, PMID 34383100, PMID 36410666
2008 (1), 2016 (1), P50AR039191 (1), P50AR044855 (1), R01AR056651 (1), R01DK051081 (1), R01DK069350 (1), U54HL081030 (1)